INNA-051

N/A

Report date: 2022/11/21 10:53:06
NME

Base Information

Drug NameINNA-051
Drug Alias NameINNA-051
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulantsToll like receptor 2 agonistsToll like receptor 6 agonists
TargetsToll like receptor 2Toll like receptor 6
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Tract DiseasesInfluenza, Human +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesENA Respiratory Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesENA Respiratory Pty Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, HumanRespiratory Tract Infections
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A